Related Experiment Videos
Sickle cell disease--pathophysiology, clinical and diagnostic implications.
Alexandra Dorn-Beineke1, Thomas Frietsch
1Department of Clinical Chemistry, Faculty of Clinical Medicine, Mannheim University, Heidelberg, Heidelberg, Germany. alexandra.dorn-beineke@ikc.ma.uni-heidelberg.de
Clinical Chemistry and Laboratory Medicine
|January 11, 2003
Summary
Sickle cell disease (SCD) diagnosis is improving, but symptom severity factors remain unclear. Red blood cell lysis resistance shows promise as an additional diagnostic tool for SCD patients with sickle cell hemoglobin (HbS).
Area of Science:
- Hematology
- Medical Diagnostics
- Genetics
Background:
- Sickle cell disease (SCD) is a genetic blood disorder with complex pathophysiology.
- Current diagnostic methods for sickle cell hemoglobin (HbS) are efficient but do not fully explain symptom variability.
- Understanding factors influencing SCD severity is crucial for patient management.
Purpose of the Study:
- To review the current knowledge on SCD pathophysiology, clinical complications, and diagnostic techniques.
- To highlight red blood cell lysis resistance as a potential additional diagnostic tool in SCD.
- To identify areas needing further research in SCD diagnostics and pathophysiology.
Main Methods:
- Literature review of existing studies on sickle cell disease.
- Analysis of current diagnostic approaches for sickle cell hemoglobin (HbS) status.
- Evaluation of red blood cell lysis resistance as a diagnostic marker.
Main Results:
- Fast and economical laboratory methods exist for determining sickle cell hemoglobin (HbS) status.
- The pathophysiology of SCD is well-studied, but factors influencing symptom severity and some lab findings require further investigation.
- Red blood cell lysis resistance is proposed as a valuable additional diagnostic tool.
Conclusions:
- While SCD diagnostics have advanced, further research is needed on factors affecting disease severity.
- Red blood cell lysis resistance warrants further investigation as a diagnostic aid for patients with sickle cell hemoglobin (HbS).
- Continued research is essential to fully understand and manage SCD complications.